Takeda Pharmaceutical Company Limited
PIPERIDINYL-3-(ARYLOXY)PROPANAMIDES AND PROPANOATES
Last updated:
Abstract:
Disclosed are compounds of Formula 1, ##STR00001## stereoisomers thereof, and pharmaceutically acceptable salts thereof, wherein L, r, s, R.sup.5, R.sup.6, R.sup.7, R.sup.9, R.sup.10, R.sup.11, R.sup.12, X.sup.1, X.sup.2, X.sup.3, X.sup.4, X.sup.13, and X.sup.14 are defined in the specification. This disclosure also relates to materials and methods for preparing compounds of Formula 1, to pharmaceutical compositions which contain them, and to their use for treating diseases, disorders, and conditions associated with SSTR4.
Status:
Application
Type:
Utility
Filling date:
28 Feb 2019
Issue date:
27 Feb 2020